• FDA announced that traditionally prepared kava beverages are recognized as food under U.S. federal law
• This provides regulatory clarity and strengthens The Calmer Co's strategic position in the U.S. market
• The Calmer Co's dual-category capability (Food + Supplement) remains a key competitive advantage

The Calmer Co. International Limited (ASX: CCO), a leading consumer packaged goods company specialising in kava beverages, natural relaxation products, and healthier alternatives to alcohol, has announced that the U.S. Food and Drug Administration (FDA) has confirmed that traditionally prepared kava beverages, made solely from kava root and water, are recognized as food under U.S. federal law. This newly released FDA clarification provides significant regulatory certainty for the global kava industry and directly enhances The Calmer Co's strategic position in the United States. The announcement strengthens both sides of the Company's U.S. portfolio: traditional drinking kava, now clearly classified as food, and tinctures, capsules, and flavoured Taki Mai® kava shots, which remain unaffected and continue to be sold as dietary supplements manufactured in the Company's FDA-registered and FDA-audited facility in Fiji. This dual-category capability (Food + Supplement) remains a key competitive advantage for The Calmer Co. The FDA's announcement comes at a time of strong growth for the Company's Fiji Kava® and Taki Mai® brands on Amazon USA, where both have delivered exceptional year-on-year performance.

The FDA's announcement confirming traditionally prepared kava beverages as food under U.S. federal law strengthens The Calmer Co's strategic position and unlocks additional growth opportunities across retail, eCommerce, and B2B partnerships.